Chronic inflammation and biomarkers: Is ageing an expression of chronic inflammation?;Chronische Inflammation und Biomarker: Ist Altern ein Ausdruck von chronischer Entzündung?

Zeitschrift fur Gerontologie und Geriatrie

Volumn 44, Issue 3, 2011, Pages 153-157

  Schmidt, D ^a   Kwetkat, A ^b   Gogol, M ^a  

^a Krankenhaus Lindenbrunn   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Biologic markers; Biological aging; Elderly; Gerontology; Inflammation

Indexed keywords

BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

AGING; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; HUMAN; INFLAMMATION; METABOLISM;

AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; REACTIVE OXYGEN SPECIES;

EID: 79958825398     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-011-0198-x     Document Type: Article

References (51)

1. Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146.
2. Robert-Koch-Institut (2009) Gesundheit und Krankheit im Alter. Beiträge zur Gesundheitsberichterstattung des Bundes. RKI, Berlin.
3. Dam RM van, Spiegelman D, Franco OH, Hu FB (2008) Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ 337: a1440.
4. Newman AB, Arnold AM, Naydeck BL et al (2003) "Successfull aging": effect of subclinical cardiovascular disease. Arch Intern Med 163: 2315-2322.
5. Fried L, Kronmal RA, Newman AB et al (1998) Risk factors for 5-year mortality in older adults. The Cardiovascular Health Study. JAMA 279: 585-592.
6. Khaw K-T, Wareham N, Bingham S et al (2008) Combined impact of health behaviours and mortality in men and women: The EPIC-Norfolk Prospective Population Study. PLoS Med 5: e12.
7. Dolan H, Crain B, Troncoso J et al (2010) Arteriosclerosis, dementia, and Alzheimer's disease in the BLSA cohort. Ann Neurol 68: 231-240.
8. Beach TG, Maarouf CL, Brooks RG et al (2011) Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's disease. BMC Geriatr 11: 3.
9. Flicker L (2010) Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging. Clin Geriatr Med 26: 17-27.
10. Fillit H, Nash DT, Rundek T, Zuckerman A (2008) Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 6: 100-118.
11. Middleton LE, Yaffe K (2009) Promising strategies for the prevention of dementia. Arch Neurol 66: 1210-1215.
12. Middleton LE, Yaffe K (2010) Targets for the prevention of dementia. J Alzheimers Dis 20: 915-924.
13. Willett WC (2002) Balancing life-style and genomics research for disease prevention. Science 296: 695-698.
14. Forman JP, Stampfer MJ, Curhan GC (2009) Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 302: 401-411.
15. Knopman DS, Roberts R (2010) Vascular risk factors: imaging and neuropathologic correlates. J Alzheimer Dis 20: 699-709.
16. Zethelius B, Berglund L, Sundström J et al (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116.
17. Melander O, Newton-Cheh C, Almgren P et al (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302: 49-57.
18. Zacho J, Tybjaerg-Hansen A, Jensen JS et al (2008) Genetically elevated c-reactive protein and ischemic vascular disease. N Engl J Med 359: 1897-1908.
19. Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 359: 2195-2207.
20. Gurven M, Kaplan H, Winking J et al (2009) Inflammation and infection do not promote arterial aging and cardiovascular disease risk factors among lean horticulturalists. PLoS One 4: e6590.
21. Helfand M, Buckley DL, Freeman M et al (2009) Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the US Preventive Services Task Force. Ann Intern Med 151: 496-507.
22. Wang TJ (2011) Usefulness of novel screening tests for cardiovascular disease. Arch Intern Med 171: 284-285.
23. Wald NJ, Morris JK (2011) Assessing risk factors as potential screening tests. A simple assessment tool. Arch Intern Med 171: 286-291.
24. The Emerging Risk Factors Collaboration (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.
25. C-Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) Association between C-reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
26. De Martinis M, Franceschi C, Monti D, Ginalsi L (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80: 219-227.
27. Gruenewald TL, Seeman TE, Ryff CD et al (2006) Combinations of biomarkers predictive of later life mortality. Proc Natl Acad Sci USA 103: 14158-14163.
28. Melander O, Newton-Cheh C, Almgren P et al (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302: 49-57.
29. Crimmins E, Vasunilashorn S, Kim JK, Alley D (2008) Biomarkers related to aging in human populations. Adv Clin Chem 46: 161-216.
30. Giunta S (2006) Is inflammaging an auto(innate)immunity subclinical syndrome? Immun Ageing 3: 12.
31. Huang H, Patel DD, Manton KG (2005) The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 10: 192-215.
32. Müller-Werdan U (2007) Inflammation and Ageing. Z Gerontol Geriatr 40: 362-365.
33. Licastro F, Candore G, Lio D et al (2005) Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing: 1-14.
34. Ridker PM (2007) Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications of longevity. Nutr Rev 65: 253-259.
35. Johnson TE (2006) Recent results: biomarkers of aging. Exp Gerontol 41: 1243-1246.
36. Rattan SIS (2008) Increased molecular damage and heterogeneity as the basis of aging. Biol Chem 389: 267-272.
37. Franceschi C, Olivieri F, Marchegiani F et al (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev 126: 351-361.
38. Vaupel JW (2010) Biodemography of human ageing. Nature 464: 536-542.
39. Sahin E, DePinho R (2010) Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464: 520-528.
40. Kenyon CJ (2010) The genetics of ageing. Nature 464: 504-512.
41. Knopman DS, Roberts R (2010) Vascular risk factors: imaging and neuropathologic correlates. J Alzheimer Dis 20: 699-709.
42. Savva GM, Stephan BCM; the Alzheimer's Society Vascular Dementia Systematic Review Group (2010) Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 41: e41-e46.
43. Kwok CS, Loke YK, Hale R et al (2011) Atrial fibrillation and incidence of dementia. A systematic review and meta-analysis. Neurology 76: 914-921.
44. Peters R, Poulter R, Beckett N et al (2009) Cardiovascular and biochemical risk factors for incident dementia in the hypertension in the very elderly trial. J Hypertens 27: 2055-2062.
45. McGuinnes B, Todd S, Passmore P, Bullock R (2009) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 7: CD004034.
46. Sanz C, Andrieu S, Sinclair A et al; REAL. FR Study Group (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 73: 1359-1366.
47. Tan ZS, Seshadri S, Beiser A et al (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease. Arch Intern Med 163: 1053-1057.
48. Rea TD, Breitner JC, Psyta BM et al (2005) Statin use and the risk of incident dementia. Arch Neurol 62: 1047-1051.
49. McGuinnes B, Craig D, Bullock R, Passmore P (2009) Statins for the prevention of dementia. Cochrane Database Syst Rev 2: CD003160.
50. Plassman BL, Williams JW, Burke JR et al (2010) Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 153: 182-193.
51. Daviglus ML, Bell CC, Berrettini W et al (2010) National Institutes of Health State-of-the-Science conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med 153: 176-181.